Mesoblast Limited (MSB)

Index:

ASX 200

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.26
  • Currency: Australian Dollars
  • Shares Issued: 482.64m

MSB Overview

Mesoblast is an Australian biotechnology company seeking to develop treatments for orthopaedic conditions, including the commercialisation of a unique adult stem cell technology aimed at the regeneration and repair of bone and cartilage. The shares listed on the ASX in December 2004.

Listings

Index: ASX 200, ASX All Ordinaries
ISIN: AU000000MSB8

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

MSB Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $0.26
Shares Issued 482.64m

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 1
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page